Home
>
US Stocks
>
AvroBio Inc
AvroBio Inc
AVRO

AvroBio Inc

$5.586.69%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
5.68
Today Low/High
5.54 / 5.75
52 Week Low/High
$5.64 / $20.07
Market Cap
$269.15M

Company Details

AVROBIO's vision is to bring personalized gene therapy to the world. The company aims to prevent, halt or reverse disease throughout the body with a single dose of gene therapy designed to drive durable expression of therapeutic protein, even in hard-to-reach tissues and organs including brain, muscle and bone. Its ex vivo lentiviral gene therapy pipeline includes clinical programs in Fabry disease, Gaucher disease type 1 and cystinosis, as well as preclinical programs in Hunter syndrome, Gaucher disease type 3 and Pompe disease. AVROBIO is powered by its industry leading plato® gene therapy platform, its foundation designed to deliver gene therapy worldwide. The company is headquartered in Cambridge, Mass., with an office in Toronto, Ontario.
Organisation
AvroBio Inc
Employees
121
Industry
Health Technology

Discover more

Frequently Asked Questions

What is AvroBio Inc share price today

Can Indians buy AvroBio Inc shares?

How can I buy AvroBio Inc shares from India?

Can Fractional shares of AvroBio Inc be purchased?

What are the documents required to start investing in AvroBio Inc stocks?

We are a SEBI registered investement advisor